Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange Post published:May 27, 2021 Post category:Press Release
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing Post published:May 26, 2021 Post category:Press Release
MYND Life Sciences Inc. Announces Public Listing on the Canadian Securities Exchange Post published:May 26, 2021 Post category:Press Release
Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development Candidates Across 153 Global Jurisdictions Post published:May 26, 2021 Post category:Press Release
Adding to their Expert Team, Albert Labs Announces the Formation and Chairs of its Two Advisory Boards Post published:May 25, 2021 Post category:Press Release
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms Post published:May 25, 2021 Post category:Press Release
PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease Post published:May 25, 2021 Post category:Press Release
Silo Pharma Submits Application for NASDAQ up-listing Post published:May 25, 2021 Post category:Press Release
Tryp Therapeutics Partners with Alcami for Proprietary Formulations Post published:May 25, 2021 Post category:Press Release
MindMed Announces Launch of Collaboration with Nextage Therapeutics’ Brain Targeting Liposome System Post published:May 24, 2021 Post category:Press Release